Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma

被引:16
作者
Bryan, Coleman J. [1 ]
Prichard, Mark N. [2 ]
Daily, Shannon [2 ]
Jefferson, Geraldine [2 ]
Hartline, Caroll [2 ]
Cassady, Kevin A. [2 ]
Hilliard, Lee [1 ]
Shimamura, Masako [2 ]
机构
[1] Univ Alabama Birmingham, Div Pediat Hematol Oncol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Div Pediat Infect Dis, Birmingham, AL USA
关键词
varicella; Oka; acyclovir; resistance; immunosuppressed; neuroblastoma;
D O I
10.1097/INF.0b013e318175d85c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A 21-month-old girl with neuroblastoma developed chronic verrucous Oka strain varicella-zoster infection during chemotherapy. Virus isolated from the patient demonstrated high-level acyclovir resistance, and its thymidine kinase had no in vitro enzymatic activity. After foscarnet therapy, she underwent stem cell transplantation without varicella reactivation. This is only the second reported case of resistant varicella zoster virus caused by Oka strain virus.
引用
收藏
页码:946 / 948
页数:3
相关论文
共 15 条
[1]   Postmarketing evaluation of the safety and effectiveness of varicella vaccine [J].
Black, S ;
Shinefield, H ;
Ray, P ;
Lewis, E ;
Hansen, J ;
Schwalbe, J ;
Coplan, P ;
Sharrar, R ;
Guess, H .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (12) :1041-1046
[2]   Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant [J].
Crassard, N ;
Souillet, AL ;
Morfin, F ;
Thouvenot, D ;
Claudy, A ;
Bertrand, Y .
ACTA PAEDIATRICA, 2000, 89 (12) :1497-1499
[3]   Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms [J].
Gilbert, C ;
Bestman-Smith, J ;
Boivin, G .
DRUG RESISTANCE UPDATES, 2002, 5 (02) :88-114
[4]   Neurologic complications of the reactivation of varicella-zoster virus. [J].
Gilden, DH ;
Kleinschmidt-DeMasters, BK ;
LaGuardia, JJ ;
Mahalingam, R ;
Cohrs, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (09) :635-645
[5]   In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication [J].
Kern, ER ;
Kushner, NL ;
Hartline, CB ;
Williams-Aziz, SL ;
Harden, EA ;
Zhou, SM ;
Zemlicka, J ;
Prichard, MN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) :1039-1045
[6]   Development of resistance to acyclovir during chronic infection with the oka vaccine strain of varicella-zoster virus, in an immunosuppressed child [J].
Levin, MJ ;
Dahl, KM ;
Weinberg, A ;
Giller, R ;
Patel, A ;
Krause, PR .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07) :954-959
[7]  
Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1
[8]  
Nikkels AF, 1999, CLIN EXP DERMATOL, V24, P346
[9]   A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation [J].
Offidani, M ;
Corvatta, L ;
Olivieri, A ;
Mele, A ;
Brunori, M ;
Montanari, M ;
Rupoli, S ;
Scalari, P ;
Leoni, P .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (10) :1414-1422
[10]   CONTINUOUS VARICELLA-ZOSTER INFECTION ASSOCIATED WITH ACYCLOVIR RESISTANCE IN A CHILD WITH AIDS [J].
PAHWA, S ;
BIRON, K ;
LIM, W ;
SWENSON, P ;
KAPLAN, MH ;
SADICK, N ;
PAHWA, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (19) :2879-2882